Central venous catheter manufacturer evidence: learn how to assess infection-control claims, clinical outcomes, sterility, and real-world safety before procurement.

Global medical consumables demand in emerging markets is rising through chronic disease, hospital expansion, cost control, and minimally invasive care. Explore the key growth drivers.

What are the main compliance risks for central venous access catheters? Explore key evidence gaps in biocompatibility, sterility, claims, labeling, and post-market surveillance.

Antimicrobial central venous catheter use lowers infection risk most in high-risk patients, longer dwell times, and units with residual CLABSI—learn when the premium is worth it.